Patent Yard Sign in
Canadian application, no grantCanada

Polynucleotides and polypeptides encoded thereby

CA 2412256 A1 · Owner: Spytek, Kimberly A. · Inventors: Malyankar, Uriel M.; Herrmann, John L.; Gerlach, Valerie L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed herein are nucleic acid sequences that encode G-coupled proteinreceptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to , the polypeptide as well as derivatives, variants, mutants or fragments of , the aforementioned polypeptide polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 27, 2001
GrantedNo grant recorded
Term endedJune 27, 2021
Patent numberCA 2412256 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedJune 27, 2001Term endedJune 27, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.